Core Viewpoint - The company announced a cash dividend distribution of 0.88 yuan per share for the first three quarters of 2025, totaling approximately 407.67 million yuan [2][4]. Distribution Plan - The cash dividend of 0.88 yuan per share will be distributed based on a total share capital of 463,258,275 shares [4]. - The distribution plan was approved at the company's first extraordinary general meeting on January 21, 2026 [2]. Distribution Recipients - The recipients of the dividend are all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the day before the equity registration [3]. Implementation Dates - The dividends will be distributed through the China Securities Depository and Clearing Corporation's fund clearing system to shareholders who have completed designated transactions [5]. - Shareholders who have not completed designated transactions will have their dividends held by the China Securities Depository and Clearing Corporation until the transactions are completed [5]. Taxation Details - For individual shareholders and securities investment funds holding A-shares, no personal income tax will be withheld at the time of dividend distribution [10]. - The actual cash dividend after tax for shareholders with a holding period of less than one month will be 0.704 yuan per share, while those holding for more than one month but less than one year will receive 0.792 yuan per share [10][11]. - For qualified foreign institutional investors (QFII), the cash dividend after a 10% withholding tax will also be 0.792 yuan per share [12]. Contact Information - For inquiries regarding this dividend distribution, shareholders can contact the company's securities affairs department at 020-29196326 [13].
广州金域医学检验集团股份有限公司2025年前三季度权益分派实施公告